DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Campath (Alemtuzumab) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (190)
Death (61)
Life Threatening Events (17)
Disability (1)

Reports by Reaction Type

Pyrexia (24)Death (22)Cytomegalovirus Infection (15)Pancytopenia (13)C-Reactive Protein Increased (12)Adenovirus Infection (12)Pneumonia (12)Dyspnoea (12)Infection (11)Pleural Effusion (11)Bronchopulmonary Aspergillosis (9)Fall (8)

Below are a few examples of reports where side effects / adverse reactions may be related to Campath (Alemtuzumab). For a complete list or a specific selection of reports, please use the links above.

Possible Campath side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 42 year old male

Reactions: Off Label Use, Fatigue, Malaise, Chest Pain, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath

Other drugs received by patient: Mycophenolate Mefetil; Cyclosporine; Prednisone TAB



Possible Campath side effects in male

Reported by a physician from Germany on 2012-08-24

Patient: male, weighing 92.8 kg (204.2 pounds)

Reactions: Tachyarrhythmia, Atrial Fibrillation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2010-07-21

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2010-07-12

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2010-07-21

Other drugs received by patient: Certoparin Sodium; Marcumar; Digoxin; Metoprolol Tartrate; Candesartan Cilexetil; Acyclovir; Levothyroxine Sodium; Pantoprazole; Prednisolone; Tamsulosin HCL; Torsemide



Possible Campath side effects in male

Reported by a consumer/non-health professional from France on 2012-08-23

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend



Possible Campath side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Phlebitis, Hydronephrosis, Adenovirus Infection, Cystitis Haemorrhagic, Human Polyomavirus Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, on first 3 days of each cycle (total 6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Folic Acid; Bactrim; Vfend; Valganciclovir



Possible Campath side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-23

Patient: 60 year old female

Reactions: Endophthalmitis, Bronchopulmonary Aspergillosis, Cerebral Artery Embolism, Fungal Endocarditis, Pancytopenia, Infection in AN Immunocompromised Host

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Fludara
    Indication: Chronic Lymphocytic Leukaemia

Mycophenolate Mofetil
    Indication: Graft Versus Host Disease



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient: male

Reactions: Phlebitis, Lymphocyte Percentage Decreased, Hydronephrosis, Arterial Thrombosis Limb, Urinary Tract Infection, Cystitis Noninfective, Human Polyomavirus Infection, Prothrombin Time Prolonged, Urethritis, Blood Fibrinogen Increased, Genitourinary Tract Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, first 3 days of each cycle (6 cycles)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, first 3 days of each cycle (6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, first 3 days of each cycle (6 cycles)
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Bactrim; Valganciclovir; Vfend; Folic Acid



Possible Campath side effects in 45 year old female

Reported by a physician from United States on 2012-08-21

Patient: 45 year old female

Reactions: Epstein-Barr Virus Infection, Splenic Infection Fungal, Mycosis Fungoides Refractory, Granuloma, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-06-01

Cisplatin
    Dosage: unk
    Indication: Mycosis Fungoides

Cyclophosphamide
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01

Daunorubicin HCL
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01

Dexamethasone
    Dosage: unk
    Indication: Mycosis Fungoides

Etoposide
    Dosage: unk
    Indication: Mycosis Fungoides

Fludara
    Dosage: 2 cycles
    Indication: Mycosis Fungoides

Ifosfamide
    Dosage: unk
    Indication: Mycosis Fungoides

Prednisone
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01

Vincristine
    Dosage: unk
    Indication: Mycosis Fungoides
    Start date: 2006-01-01



Possible Campath side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: 51 year old female

Reactions: Nausea, Diarrhoea, Clostridium Difficile Colitis, Microangiopathic Haemolytic Anaemia, Muscular Weakness, Renal Failure Acute, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Start date: 2012-05-01

Campath
    Dosage: 100 mg, unknown/d
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-23

Fludarabine Phosphate
    Dosage: 355 mg, total dose
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-23

Fludarabine Phosphate
    Dosage: unk
    Start date: 2012-05-01

Melphalan Hydrochloride
    Dosage: 333 mg, total dose
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-23

Melphalan Hydrochloride
    Dosage: unk
    Start date: 2012-05-02

Prograf
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Sprycel
    Dosage: unk
    Administration route: Oral
    Start date: 2012-04-26

Sprycel
    Dosage: unk
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-01-23



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Cystitis Haemorrhagic, Adenovirus Infection, Human Polyomavirus Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Vfend; Bactrim; Valganciclovir; Folic Acid



Possible Campath side effects in male

Reported by a consumer/non-health professional from France on 2012-08-17

Patient: male, weighing 79.0 kg (173.8 pounds)

Reactions: Abdominal Pain Lower, Prostatitis, Adenovirus Infection, Dysuria, Cystitis Haemorrhagic, Pollakiuria, Human Polyomavirus Infection, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, 3 times per 1 cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Valganciclovir; Vfend; Folic Acid; Bactrim



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: male

Reactions: Hydronephrosis, Urinary Tract Infection, Cystitis Noninfective, Urethritis, Human Polyomavirus Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg/m2, unk
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Fludara
    Dosage: 80 mg/m2, unk
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-07-15
    End date: 2008-12-03

Other drugs received by patient: Bactrim; Vfend; Valganciclovir; Folic Acid



Possible Campath side effects in 74 year old female

Reported by a physician from United States on 2012-08-16

Patient: 74 year old female, weighing 75.9 kg (167.0 pounds)

Reactions: Blood Culture Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Arzerra
    Dosage: 2000mg cyclic
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-06-19

Campath
    Dosage: 30mg weekly
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-06-05

Other drugs received by patient: Mirtazapine; Esomeprazole Magnesium; Humalog; Prochlorperazine; Alprazolam; Fluconazole; Rosuvastatin; Ramipril; Pentamidine Isethionate; Estradiol; Nepafenac; Ferrous Sulfate TAB; Pred Forte; Lantus; Acyclovir; Cyanocobalamin + Folic Acid + Pyridoxine Hydrochloride; Vesicare



Possible Campath side effects in 13 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: 13 year old female

Reactions: Diarrhoea, Adenovirus Infection

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Fludara
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Melphalan Hydrochloride
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen



Possible Campath side effects in 3 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: 3 year old male

Reactions: Adenovirus Infection, Respiratory Distress

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Cord Blood Transplant Therapy

Fludara
    Dosage: unk
    Indication: Cord Blood Transplant Therapy

Melphalan Hydrochloride
    Dosage: unk
    Indication: Cord Blood Transplant Therapy



Possible Campath side effects in female

Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-08-09

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: Lymphocyte Count Increased, Dyspnoea, Vomiting, Nausea, Graft Dysfunction, Tachycardia, Hyperhidrosis, Pallor, Convulsion, Tremor, Muscle Spasms

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, unk
    Indication: Transplant Rejection
    Start date: 2012-07-29

Campath
    Dosage: unk

Other drugs received by patient: Hydrocortisone; Dithiaden; Paralen; Solu-Medrol; Immune Globulin NOS; Dithiaden



Possible Campath side effects in female

Reported by a physician from United States on 2012-08-09

Patient: female

Reactions: Off Label Use, Autoimmune Neutropenia

Drug(s) suspected as cause:
Campath



Possible Campath side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-06

Patient: 60 year old female

Reactions: Night Sweats, Endophthalmitis, Fungal Endocarditis, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia

Corticosteroid NOS
    Dosage: unk
    Indication: Graft Versus Host Disease

Cyclophosphamide
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia

Fludara
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia

Mycophenolate Mofetil
    Dosage: unk
    Indication: Graft Versus Host Disease



Possible Campath side effects in male

Reported by a pharmacist from United States on 2012-07-23

Patient: male, weighing 55.3 kg (121.7 pounds)

Reactions: Atelectasis, Renal Haemorrhage, Hydronephrosis, Subcutaneous Emphysema, Ascites, Cholelithiasis, Off Label Use, Haemoglobin Decreased, Haematocrit Decreased, Pleural Effusion, Thrombocytopenia, Incision Site Haemorrhage

Drug(s) suspected as cause:
Berinert
    Dosage: 1100 units ivp over 6 min via syringe pump),
    Indication: Transplant Rejection
    Start date: 2012-06-16

Berinert
    Dosage: 1100 units ivp over 6 min via syringe pump),
    Indication: Transplant Rejection
    Start date: 2012-06-18

Campath
    Dosage: 30 mg x 1 pdo#0 subcutaneous
    Indication: Premedication

Cellcept
    Dosage: 500 mg bid, oral
    Administration route: Oral

Other drugs received by patient: Prograf; Prednisone; Ganciclovir



Possible Campath side effects in 54 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-23

Patient: 54 year old male

Reactions: Abdominal Pain, Small Intestine Ulcer

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 1xper cycle for 71 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-05-09

Cyclophosphamide
    Dosage: 1520 mg, unk, 1x per cycle for 106 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-06-13

Doxorubicin Hydrochloride
    Dosage: 102 mg, unk, 1x per cycle for 106 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-06-13

Pegfilgrastim
    Dosage: 6 mg, unk, 1xper cycle for 106 days
    Indication: T-Cell Lymphoma
    Start date: 2012-03-03
    End date: 2012-06-16

Prednisone
    Dosage: 100 mg, unk,5xper cycle for 110 days
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-06-17

Vincristine
    Dosage: 2 mg, unk, 1x per cycle for 36 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-04-04



Possible Campath side effects in female

Reported by a lawyer from United States on 2012-07-20

Patient: female

Reactions: Abdominal Pain, Upper Limb Fracture, Vulval Ulceration, Face Oedema, Upper Respiratory Tract Infection, Phlebolith, Hypotension, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Chest Pain, Bone Disorder, Depression, Bundle Branch Block Left, Discomfort, Impaired Healing, Sepsis, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Hypocalcaemia, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Stomatitis, Pneumonia, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Confusional State, Atelectasis, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Sinusitis, Hallucination, Venous Lake, RIB Fracture, Pain in JAW, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Osteolysis, Rash, Deformity, Facial Pain, Pulmonary Fibrosis, Anxiety, Mucosal Inflammation, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, qmo
    Indication: Multiple Myeloma

Campath
    End date: 2004-09-27

Thalidomide

Other drugs received by patient: Mevacor; COD-Liver OIL; Multivite; Acyclovir; Neurontin; Peridex; Scopolamine; Darvocet-N 50; Tylenol; Magnesium Sulfate; Prednisone TAB; Aspirin; Hydralazine HCL; Calcium; Lovastatin; Ativan; Chemotherapeutics NOS; Procrit / 00909301 /; MS Contin; Solu-Medrol; Augmentin '125'; Revlimid



Possible Campath side effects in 82 year old female

Reported by a consumer/non-health professional from United States on 2012-07-19

Patient: 82 year old female, weighing 45.1 kg (99.2 pounds)

Reactions: Hemiparesis, Progressive Multifocal Leukoencephalopathy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: cycle 2: on days 1, 3, 5, 8, 10, 13, 15, 17, 19, 22, 24, 26
    Start date: 2012-01-01
    End date: 2012-01-01

Campath
    Dosage: 3 mg, cycle 1: day 1
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-01
    End date: 2012-01-01

Campath
    Dosage: 30 mg, cycle 1: day 3
    Start date: 2012-01-01
    End date: 2012-01-01

Campath
    Dosage: 10 mg, cycle 1: day 2
    Start date: 2012-01-01
    End date: 2012-01-01

Campath
    Dosage: cycle 1: on days 6, 8, 10, 13, 15, 17, 20, 22, 24, 27, 29, 31
    Start date: 2012-01-01
    End date: 2012-01-01

Rituximab
    Dosage: 375 mg/m2, on days 8, 15, 22, 29 of cycle 1
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-01-01
    End date: 2012-01-01

Rituximab
    Dosage: 375 mg/m2, on days 3, 10, 17, 24 of cycle 2
    Start date: 2012-01-01
    End date: 2012-01-01



Possible Campath side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-17

Patient: female, weighing 45.1 kg (99.2 pounds)

Reactions: Hemiparesis, Progressive Multifocal Leukoencephalopathy

Drug(s) suspected as cause:
Campath
    Dosage: 360 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 2040 mg



Possible Campath side effects in 54 year old male

Reported by a physician from Germany on 2012-07-13

Patient: 54 year old male

Reactions: Abdominal Pain, Small Intestine Ulcer

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 1xper cycle for 71 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-05-09

Cyclophosphamide
    Dosage: 1520 mg, unk, 1x per cycle for 106 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-06-13

Doxorubicin HCL
    Dosage: 102 mg, unk, 1x per cycle for 106 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-06-13

Pegfilgrastim
    Dosage: 6 mg, unk, 1xper cycle for 106 days
    Indication: T-Cell Lymphoma
    Start date: 2012-03-03
    End date: 2012-06-16

Prednisone
    Dosage: 100 mg, unk,5xper cycle for 110 days
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-06-17

Vincristine
    Dosage: 2 mg, unk, 1x per cycle for 36 days
    Indication: T-Cell Lymphoma
    Start date: 2012-02-29
    End date: 2012-04-04



Possible Campath side effects in 33 year old female

Reported by a physician from United States on 2012-07-13

Patient: 33 year old female

Reactions: Enterococcal Bacteraemia, Retinal Haemorrhage, Graft Versus Host Disease, Pulmonary Alveolar Haemorrhage, Microsporidia Infection, Retinal Disorder, Meningitis, Hydrocephalus

Adverse event resulted in: death

Drug(s) suspected as cause:
Campath
    Dosage: unk
    Indication: Prophylaxis Against Graft Versus Host Disease

Thymoglobulin
    Dosage: unk
    Indication: Bone Marrow Conditioning Regimen

Other drugs received by patient: Cyclophosphamide; Cyclosporine; Fludarabine Phosphate



Possible Campath side effects in 61 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-13

Patient: 61 year old male

Reactions: Candida Pneumonia, Bronchopneumonia, Febrile Neutropenia, Respiratory Distress, Organising Pneumonia, Respiratory Failure, Interstitial Lung Disease, Pseudomonal Sepsis, Opportunistic Infection, Stenotrophomonas Sepsis, Tracheitis, Septic Shock, Sinusitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-08

Campath
    Dosage: 30 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-23

Cyclophosphamide
    Dosage: 1380 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Cyclophosphamide
    Dosage: 690 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Doxorubicin HCL
    Dosage: 92 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Doxorubicin HCL
    Dosage: 46 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Pegfilgrastim
    Dosage: 6 mg, qd
    Start date: 2010-03-01
    End date: 2010-03-01

Pegfilgrastim
    Dosage: 3 mg, qd
    Indication: T-Cell Lymphoma

Posaconazole
    Indication: Prophylaxis

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2010-02-22
    End date: 2010-02-26

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-11

Vincristine
    Dosage: 2 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07



Possible Campath side effects in male

Reported by a consumer/non-health professional from Germany on 2012-07-10

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Candida Pneumonia, Bronchopneumonia, Tachycardia, Atrial Fibrillation, Febrile Neutropenia, General Physical Health Deterioration, Lactic Acidosis, Respiratory Distress, Respiratory Failure, Skin Lesion, Pseudomonal Sepsis, Tracheitis, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-08

Campath
    Dosage: 30 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-23

Cyclophosphamide
    Dosage: 690 mg, once
    Start date: 2010-02-22
    End date: 2010-02-22

Cyclophosphamide
    Dosage: 1380 mg, unk
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-07

Doxorubicin HCL
    Dosage: 92 mg, unk
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-07

Doxorubicin HCL
    Dosage: 46 mg, once
    Start date: 2010-02-22
    End date: 2010-02-22

Pegfilgrastim
    Dosage: 6 mg, once
    Start date: 2010-03-01
    End date: 2010-03-01

Pegfilgrastim
    Dosage: 3 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-11

Prednisone
    Dosage: 100 mg, qdx5
    Administration route: Oral
    Start date: 2010-02-22
    End date: 2010-02-26

Vasopressin
    Dosage: unk
    Indication: Blood Pressure Management

Vincristine
    Dosage: 2 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-22

Vincristine
    Dosage: 2 mg, unk
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2010-01-07
    End date: 2010-01-07

Other drugs received by patient: Zienam; Posaconazole; Taranic; Zienam; Taranic; Candiohermal; Candiohermal



Possible Campath side effects in 61 year old male

Reported by a consumer/non-health professional from Germany on 2012-07-10

Patient: 61 year old male

Reactions: Respiratory Failure, Bronchopneumonia, Pseudomonal Sepsis, Febrile Neutropenia, Septic Shock, Tracheitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-08

Campath
    Dosage: 30 mg, qd
    Start date: 2010-02-22
    End date: 2010-02-23

Cyclophosphamide
    Dosage: 1380 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Cyclophosphamide
    Dosage: 690 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Doxorubicin HCL
    Dosage: 46 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22

Doxorubicin HCL
    Dosage: 92 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Pegfilgrastim
    Dosage: 3 mg, qd
    Indication: T-Cell Lymphoma

Pegfilgrastim
    Dosage: 6 mg, qd
    Start date: 2010-03-01
    End date: 2010-03-01

Posaconazole
    Indication: Prophylaxis

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-11

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2010-02-22
    End date: 2010-02-26

Vincristine
    Dosage: 2 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2010-01-07
    End date: 2010-01-07

Vincristine
    Dosage: 2 mg, unk
    Start date: 2010-02-22
    End date: 2010-02-22



Possible Campath side effects in 73 year old male

Reported by a physician from Germany on 2012-07-06

Patient: 73 year old male

Reactions: Stenotrophomonas Infection, Febrile Neutropenia, Atrial Fibrillation, Ileus Paralytic, Multi-Organ Failure, Pneumonia Bacterial, Respiratory Failure, Cardiac Failure, Oesophagitis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, q2w
    Indication: T-Cell Lymphoma
    Start date: 2009-06-25
    End date: 2009-09-04

Cyclophosphamide
    Dosage: 1500 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2009-06-25
    End date: 2009-09-03

Doxorubicin HCL
    Dosage: 100 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2009-06-25
    End date: 2009-09-03

Pegfilgrastim
    Dosage: 6 mg, q2w
    Indication: T-Cell Lymphoma
    Start date: 2009-06-29
    End date: 2009-09-06

Pegfilgrastim
    Indication: Prophylaxis

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2009-06-17
    End date: 2009-09-10

Vincristine
    Dosage: 1 mg, unk
    Indication: T-Cell Lymphoma
    Start date: 2009-06-17
    End date: 2009-09-03

Other drugs received by patient: Ciprofloxacin



Possible Campath side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-06

Patient: 76 year old male

Reactions: Cerebral Ischaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, q2w
    Indication: T-Cell Lymphoma
    Start date: 2011-06-30
    End date: 2011-07-29

Cyclophosphamide
    Dosage: 750 mg/m2, q2w on day 1
    Indication: T-Cell Lymphoma
    Start date: 2011-06-30
    End date: 2011-07-29

Doxorubicin HCL
    Dosage: 50 mg/m2, q2w on day 1
    Indication: T-Cell Lymphoma
    Start date: 2011-06-30
    End date: 2011-07-29

Prednisone
    Dosage: 100 mg x 4 days q2w
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2011-06-21
    End date: 2011-08-02

Vincristine
    Dosage: 1.4 mg/m2, q2w on day 1
    Indication: T-Cell Lymphoma
    Start date: 2011-06-21
    End date: 2011-07-29

Other drugs received by patient: Metoprolol Tartrate; Valaciclovir; Metoprolol Succinate



Possible Campath side effects in female

Reported by a consumer/non-health professional from Germany on 2012-07-06

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, bid
    Start date: 2009-07-23

Campath
    Dosage: 20 mg, qd
    Start date: 2009-07-07

Campath
    Dosage: 30 mg, qd
    Start date: 2009-08-06
    End date: 2009-08-06

Campath
    Dosage: 30 mg, qd
    Start date: 2009-09-11
    End date: 2009-10-22

Campath
    Dosage: 10 mg, qd
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-20

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-21

Cyclophosphamide
    Dosage: 1250 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-07-07

Cyclophosphamide
    Dosage: 1200 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-07

Doxorubicin HCL
    Dosage: 80 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-21

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-09-08
    End date: 2009-09-08

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-07-23

Doxorubicin HCL
    Dosage: 80 mg, once
    Start date: 2009-08-20

Filgrastim
    Dosage: 3000 iu, unk
    Start date: 2009-07-26
    End date: 2009-08-27

Filgrastim
    Dosage: unk on days 4 through 13 of course 5
    Start date: 2009-08-20

Filgrastim
    Dosage: unk on days 4 through 12 of course 6
    Start date: 2009-09-08

Filgrastim
    Dosage: unk on days 4, 5, 6 of course 1
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-23

Filgrastim
    Dosage: unk on days 4 through 15 of course 2
    Start date: 2009-07-07

Filgrastim
    Dosage: unk on days 4 through 8 and day 13 of course 3
    Start date: 2009-07-23

Filgrastim
    Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
    Start date: 2009-08-06

Filgrastim
    Dosage: 30000 iu, qd
    Start date: 2009-09-11
    End date: 2009-09-19

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-06-23

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-09-11

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-07

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-08-06
    End date: 2009-08-10

Prednisone
    Dosage: 100 mg, qd for 5 days
    Administration route: Oral
    Start date: 2009-07-23

Prednisone
    Dosage: 100 mg, unk
    Administration route: Oral
    Start date: 2009-09-08
    End date: 2009-09-08

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-06-23

Vincristine
    Dosage: 1 mg, once
    Indication: Peripheral T-Cell Lymphoma Unspecified
    Start date: 2009-06-15

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-20

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-23

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-07

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-07-21

Vincristine

Vincristine
    Dosage: 2 mg, once
    Start date: 2009-08-06
    End date: 2009-08-20

Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017